SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-042274
Filing Date
2010-08-05
Accepted
2010-08-05 13:07:43
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-12851_110q.htm 10-Q 968772
2 EX-10.1 a10-12851_1ex10d1.htm EX-10.1 65705
3 EX-31.1 a10-12851_1ex31d1.htm EX-31.1 19445
4 EX-31.2 a10-12851_1ex31d2.htm EX-31.2 20610
5 EX-32.1 a10-12851_1ex32d1.htm EX-32.1 10280
  Complete submission text file 0001104659-10-042274.txt   1086404
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 10993627
SIC: 2835 In Vitro & In Vivo Diagnostic Substances